Abiraterone Acetate-5,6-Epoxide

Status: Under Development

Abiraterone Acetate-5,6-Epoxide or (3S,6aS,6bS,9aS,11aS,11bR)-9a,11b-dimethyl-9-(pyridin-3-yl)-1,2,3,4,5a,6,6a,6b,7,9a,10,11,11a,11b-tetradecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-3-yl acetate, that inhibits 17a-hydroxylase CYP17 and is used in the treatment of prostate cancer.

Additional information on Abiraterone Acetate-5 | 6-Epoxide

Catalogue No. VL830024
Molecular Formula C26H33NO3
Molecular Weight 407.55 g/mol
Parent drug Abiraterone
IUPAC Name (3S, 6aS, 6bS, 9aS, 11aS, 11bR)-9a, 11b-dimethyl-9-(pyridin-3-yl)-1, 2, 3, 4, 5a, 6, 6a, 6b, 7, 9a, 10, 11, 11a, 11b-tetradecahydrocyclopenta[1, 2]phenanthro[8a, 9-b]oxiren-3-yl acetate
Synonyms N/A
References Goldberg, Tamara, and Evangelina Berrios-Colon. “Abiraterone (Zytiga), a Novel Agent for the Management of Castration-Resistant Prostate Cancer.” Pharmacy and Therapeutics, vol. 38, no. 1, 1 Jan. 2013, pp. 23–26, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628169/.
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Abiraterone Acetate-5,6-Epoxide

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.